Semaglutide can cause side effects like nausea, vomiting, and diarrhea, and in some cases, it can increase the risk of pancreatitis
The protective effect of GLP-1 medications was consistent across racial groups, including Black and white females, and was independent of diabetes status, age, BMI, and breast density
The majority of weight loss drug lawsuits filed claim that the companies failed to warn patients about the risk of delayed gastric emptying, severe gastroparesis, intestinal blockages, and vision loss, such as non-arteritic anterior ischemic optic neuropathy (NAION)
PEBP1 Wardens Ferroptosis by Enabling Lipoxygenase Generation of Lipid Death Signals